FEATURED COMPANIES
- Biomatlante SA
- DENTSPLY SIRONA Inc.
- Envista Holdings Corp.
- Geistlich Pharma AG
- Henry Schein Inc.
- Medtronic Plc
- MORE
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Global Dental Biomaterials Market: About this market
The dental biomaterials market analysis considers sales from bone grafts and membranes and tissue regeneration products. Our study also finds the sales of dental biomaterials in Asia, Europe, North America, and ROW. In 2019, the bone grafts segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the launch of innovative grafts and technological advances will play a significant role in the bone grafts segment to maintain its market position. Also, our global dental biomaterials market report looks at factors such as the increasing prevalence of dental conditions, new product launches, and the growing number of M&A activities. However, high costs associated with medicinal procedures, presence of substitutes and lack of awareness in developing countries, and stringent regulations and complications with dental bone grafts may hamper the growth of the dental biomaterials industry over the forecast period.
Global Dental Biomaterials Market: Overview
Increasing prevalence of dental conditions
There is a growing prevalence of dental disorders such as tooth decay and periodontal diseases owing to changing food habits and lifestyles, consumption of tobacco, smoking, and poor oral health. The growth of the geriatric population has further increased the prevalence of periodontal diseases across the world. This has increased the demand for biomaterials for tissue engineering and several methods of regenerative periodontal therapies, such as the use of bone graft, barrier membrane, and combined procedures for the treatment of periodontal diseases. Thus, the increasing prevalence of dental conditions will lead to the expansion of the global dental biomaterials market at a CAGR of almost 7% during the forecast period.
Technological advances and innovations in dental biomaterials
Digital technology and diagnostic tools such as CAD/CAM, digitally assisted treatment planning for implant surgery/restorations, and caries diagnosis tools have shifted dentistry to a new level. The application of artificial intelligence (Al) is expected to have a significant impact on dental care, which will open a range of applications for dental biomaterials. New grafts and molecules with biomimetic and biological properties play a crucial role in the functional rehabilitation of bone defects. This development is expected to have a positive impact on the overall market growth.
Competitive Landscape
With the presence of several major players, the global dental biomaterials market is fragmented. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading milk chocolate manufacturers, that include Advanced Medical Solutions Group Plc, Biomatlante SA, DENTSPLY SIRONA Inc., Envista Holdings Corp., Geistlich Pharma AG, Henry Schein Inc., Medtronic Plc, Straumann Holding AG, Tissue Regenix Group Plc, and Zimmer Biomet Holdings Inc.
Also, the dental biomaterials market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The dental biomaterials market analysis considers sales from bone grafts and membranes and tissue regeneration products. Our study also finds the sales of dental biomaterials in Asia, Europe, North America, and ROW. In 2019, the bone grafts segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the launch of innovative grafts and technological advances will play a significant role in the bone grafts segment to maintain its market position. Also, our global dental biomaterials market report looks at factors such as the increasing prevalence of dental conditions, new product launches, and the growing number of M&A activities. However, high costs associated with medicinal procedures, presence of substitutes and lack of awareness in developing countries, and stringent regulations and complications with dental bone grafts may hamper the growth of the dental biomaterials industry over the forecast period.
Global Dental Biomaterials Market: Overview
Increasing prevalence of dental conditions
There is a growing prevalence of dental disorders such as tooth decay and periodontal diseases owing to changing food habits and lifestyles, consumption of tobacco, smoking, and poor oral health. The growth of the geriatric population has further increased the prevalence of periodontal diseases across the world. This has increased the demand for biomaterials for tissue engineering and several methods of regenerative periodontal therapies, such as the use of bone graft, barrier membrane, and combined procedures for the treatment of periodontal diseases. Thus, the increasing prevalence of dental conditions will lead to the expansion of the global dental biomaterials market at a CAGR of almost 7% during the forecast period.
Technological advances and innovations in dental biomaterials
Digital technology and diagnostic tools such as CAD/CAM, digitally assisted treatment planning for implant surgery/restorations, and caries diagnosis tools have shifted dentistry to a new level. The application of artificial intelligence (Al) is expected to have a significant impact on dental care, which will open a range of applications for dental biomaterials. New grafts and molecules with biomimetic and biological properties play a crucial role in the functional rehabilitation of bone defects. This development is expected to have a positive impact on the overall market growth.
Competitive Landscape
With the presence of several major players, the global dental biomaterials market is fragmented. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading milk chocolate manufacturers, that include Advanced Medical Solutions Group Plc, Biomatlante SA, DENTSPLY SIRONA Inc., Envista Holdings Corp., Geistlich Pharma AG, Henry Schein Inc., Medtronic Plc, Straumann Holding AG, Tissue Regenix Group Plc, and Zimmer Biomet Holdings Inc.
Also, the dental biomaterials market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Biomatlante SA
- DENTSPLY SIRONA Inc.
- Envista Holdings Corp.
- Geistlich Pharma AG
- Henry Schein Inc.
- Medtronic Plc
- MORE
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 08: GEOGRAPHIC LANDSCAPE
PART 10: DRIVERS AND CHALLENGES
Exhibit 01: Global healthcare supplies market
Exhibit 02: Segments of global healthcare supplies market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Product overview
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2019
Exhibit 18: Product - Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: Bone grafts - Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Bone grafts - Year-over-year growth 2020-2024 (%)
Exhibit 22: Membranes and tissue regeneration products - Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Membranes and tissue regeneration products - Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
Exhibit 30: Europe - Market size and forecast 2019-2024 ($ millions)
Exhibit 31: Europe - Year-over-year growth 2020-2024 (%)
Exhibit 32: Asia - Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Population aged 65 years and above 2015 and 2018 (% of total population)
Exhibit 34: Asia - Year-over-year growth 2020-2024 (%)
Exhibit 35: ROW - Market size and forecast 2019-2024 ($ millions)
Exhibit 36: ROW - Year-over-year growth 2020-2024 (%)
Exhibit 37: Key leading countries
Exhibit 38: Market opportunity
Exhibit 39: Product launch details
Exhibit 40: M&A and their market impact analysis
Exhibit 41: Impact of drivers and challenges
Exhibit 42: Types of strategic alliances
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Vendors covered
Exhibit 46: Vendor classification
Exhibit 47: Market positioning of vendors
Exhibit 48: Advanced Medical Solutions Group Plc - Vendor overview
Exhibit 49: Advanced Medical Solutions Group Plc - Business segments
Exhibit 50: Advanced Medical Solutions Group Plc - Geographic focus
Exhibit 51: Advanced Medical Solutions Group Plc - Segment focus
Exhibit 52: Advanced Medical Solutions Group Plc - Key offerings
Exhibit 53: Advanced Medical Solutions Group Plc - Key customers
Exhibit 54: Biomatlante SA - Vendor overview
Exhibit 55: Biomatlante SA - Product segments
Exhibit 56: Biomatlante SA - Organizational developments
Exhibit 57: Biomatlante SA - Key offerings
Exhibit 58: Biomatlante SA - Key customers
Exhibit 59: DENTSPLY SIRONA Inc. - Vendor overview
Exhibit 60: DENTSPLY SIRONA Inc. - Business segments
Exhibit 61: DENTSPLY SIRONA Inc. - Organizational developments
Exhibit 62: DENTSPLY SIRONA Inc. - Geographic focus
Exhibit 63: DENTSPLY SIRONA Inc. - Segment focus
Exhibit 64: DENTSPLY SIRONA Inc. - Key offerings
Exhibit 65: DENTSPLY SIRONA Inc. - Key customers
Exhibit 66: Envista Holdings Corp. - Vendor overview
Exhibit 67: Envista Holdings Corp. - Business segments
Exhibit 68: Envista Holdings Corp. - Key offerings
Exhibit 69: Envista Holdings Corp. - Key customers
Exhibit 70: Geistlich Pharma AG - Vendor overview
Exhibit 71: Geistlich Pharma AG - Product segments
Exhibit 72: Geistlich Pharma AG - Organizational developments
Exhibit 73: Geistlich Pharma AG - Key offerings
Exhibit 74: Geistlich Pharma AG - Key customers
Exhibit 75: Henry Schein Inc. - Vendor overview
Exhibit 76: Henry Schein Inc. - Product segments
Exhibit 77: Henry Schein Inc. - Organizational developments
Exhibit 78: Henry Schein Inc. - Geographic focus
Exhibit 79: Henry Schein Inc. - Segment focus
Exhibit 80: Henry Schein Inc. - Key offerings
Exhibit 81: Henry Schein Inc. - Key customers
Exhibit 82: Medtronic Plc - Vendor overview
Exhibit 83: Medtronic Plc - Business segments
Exhibit 84: Medtronic Plc - Organizational developments
Exhibit 85: Medtronic Plc - Geographic focus
Exhibit 86: Medtronic Plc - Segment focus
Exhibit 87: Medtronic Plc - Key offerings
Exhibit 88: Medtronic Plc - Key customers
Exhibit 89: Straumann Holding AG - Vendor overview
Exhibit 90: Straumann Holding AG - Product segments
Exhibit 91: Straumann Holding AG - Organizational developments
Exhibit 92: Straumann Holding AG - Geographic focus
Exhibit 93: Straumann Holding AG - Segment focus
Exhibit 94: Straumann Holding AG - Key offerings
Exhibit 95: Straumann Holding AG - Key customers
Exhibit 96: Tissue Regenix Group Plc - Vendor overview
Exhibit 97: Tissue Regenix Group Plc - Product segments
Exhibit 98: Tissue Regenix Group Plc - Organizational developments
Exhibit 99: Tissue Regenix Group Plc - Geographic focus
Exhibit 100: Tissue Regenix Group Plc - Segment focus
Exhibit 101: Tissue Regenix Group Plc - Key offerings
Exhibit 102: Tissue Regenix Group Plc - Key customers
Exhibit 103: Zimmer Biomet Holdings Inc. - Vendor overview
Exhibit 104: Zimmer Biomet Holdings Inc. - Product segments
Exhibit 105: Zimmer Biomet Holdings Inc. - Organizational developments
Exhibit 106: Zimmer Biomet Holdings Inc. - Geographic focus
Exhibit 107: Zimmer Biomet Holdings Inc. - Segment focus
Exhibit 108: Zimmer Biomet Holdings Inc. - Key offerings
Exhibit 109: Zimmer Biomet Holdings Inc. - Key customers
Exhibit 110: Validation techniques employed for market sizing
Exhibit 111: Definition of market positioning of vendors
PART 02: SCOPE OF THE REPORT
- Preface
- Currency conversion rates for US$
- Market ecosystem
- Market characteristics
- Value chain analysis
- Market segmentation analysis
- Market definition
- Market sizing 2019
- Market size and forecast 2019-2024
- Market outlook
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
- Market segmentation by product
- Comparison by product
- Bone grafts - Market size and forecast 2019-2024
- Membranes and tissue regeneration products -
- Market size and forecast 2019-2024
- Market opportunity by product
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2019-2024
- Europe - Market size and forecast 2019-2024
- Asia - Market size and forecast 2019-2024
- ROW - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity
PART 10: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
- Growing number of strategic alliances
- Technological advances and innovations in dental biomaterials
- Overview
- Landscape disruption
- Competitive scenario
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Advanced Medical Solutions Group Plc
- Biomatlante SA
- DENTSPLY SIRONA Inc.
- Envista Holdings Corp.
- Geistlich Pharma AG
- Henry Schein Inc.
- Medtronic Plc
- Straumann Holding AG
- Tissue Regenix Group Plc
- Zimmer Biomet Holdings Inc.
- Research methodology
- List of abbreviations
- Definition of market positioning of vendors
Exhibit 01: Global healthcare supplies market
Exhibit 02: Segments of global healthcare supplies market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Product overview
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2019
Exhibit 18: Product - Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: Bone grafts - Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Bone grafts - Year-over-year growth 2020-2024 (%)
Exhibit 22: Membranes and tissue regeneration products - Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Membranes and tissue regeneration products - Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
Exhibit 30: Europe - Market size and forecast 2019-2024 ($ millions)
Exhibit 31: Europe - Year-over-year growth 2020-2024 (%)
Exhibit 32: Asia - Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Population aged 65 years and above 2015 and 2018 (% of total population)
Exhibit 34: Asia - Year-over-year growth 2020-2024 (%)
Exhibit 35: ROW - Market size and forecast 2019-2024 ($ millions)
Exhibit 36: ROW - Year-over-year growth 2020-2024 (%)
Exhibit 37: Key leading countries
Exhibit 38: Market opportunity
Exhibit 39: Product launch details
Exhibit 40: M&A and their market impact analysis
Exhibit 41: Impact of drivers and challenges
Exhibit 42: Types of strategic alliances
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Vendors covered
Exhibit 46: Vendor classification
Exhibit 47: Market positioning of vendors
Exhibit 48: Advanced Medical Solutions Group Plc - Vendor overview
Exhibit 49: Advanced Medical Solutions Group Plc - Business segments
Exhibit 50: Advanced Medical Solutions Group Plc - Geographic focus
Exhibit 51: Advanced Medical Solutions Group Plc - Segment focus
Exhibit 52: Advanced Medical Solutions Group Plc - Key offerings
Exhibit 53: Advanced Medical Solutions Group Plc - Key customers
Exhibit 54: Biomatlante SA - Vendor overview
Exhibit 55: Biomatlante SA - Product segments
Exhibit 56: Biomatlante SA - Organizational developments
Exhibit 57: Biomatlante SA - Key offerings
Exhibit 58: Biomatlante SA - Key customers
Exhibit 59: DENTSPLY SIRONA Inc. - Vendor overview
Exhibit 60: DENTSPLY SIRONA Inc. - Business segments
Exhibit 61: DENTSPLY SIRONA Inc. - Organizational developments
Exhibit 62: DENTSPLY SIRONA Inc. - Geographic focus
Exhibit 63: DENTSPLY SIRONA Inc. - Segment focus
Exhibit 64: DENTSPLY SIRONA Inc. - Key offerings
Exhibit 65: DENTSPLY SIRONA Inc. - Key customers
Exhibit 66: Envista Holdings Corp. - Vendor overview
Exhibit 67: Envista Holdings Corp. - Business segments
Exhibit 68: Envista Holdings Corp. - Key offerings
Exhibit 69: Envista Holdings Corp. - Key customers
Exhibit 70: Geistlich Pharma AG - Vendor overview
Exhibit 71: Geistlich Pharma AG - Product segments
Exhibit 72: Geistlich Pharma AG - Organizational developments
Exhibit 73: Geistlich Pharma AG - Key offerings
Exhibit 74: Geistlich Pharma AG - Key customers
Exhibit 75: Henry Schein Inc. - Vendor overview
Exhibit 76: Henry Schein Inc. - Product segments
Exhibit 77: Henry Schein Inc. - Organizational developments
Exhibit 78: Henry Schein Inc. - Geographic focus
Exhibit 79: Henry Schein Inc. - Segment focus
Exhibit 80: Henry Schein Inc. - Key offerings
Exhibit 81: Henry Schein Inc. - Key customers
Exhibit 82: Medtronic Plc - Vendor overview
Exhibit 83: Medtronic Plc - Business segments
Exhibit 84: Medtronic Plc - Organizational developments
Exhibit 85: Medtronic Plc - Geographic focus
Exhibit 86: Medtronic Plc - Segment focus
Exhibit 87: Medtronic Plc - Key offerings
Exhibit 88: Medtronic Plc - Key customers
Exhibit 89: Straumann Holding AG - Vendor overview
Exhibit 90: Straumann Holding AG - Product segments
Exhibit 91: Straumann Holding AG - Organizational developments
Exhibit 92: Straumann Holding AG - Geographic focus
Exhibit 93: Straumann Holding AG - Segment focus
Exhibit 94: Straumann Holding AG - Key offerings
Exhibit 95: Straumann Holding AG - Key customers
Exhibit 96: Tissue Regenix Group Plc - Vendor overview
Exhibit 97: Tissue Regenix Group Plc - Product segments
Exhibit 98: Tissue Regenix Group Plc - Organizational developments
Exhibit 99: Tissue Regenix Group Plc - Geographic focus
Exhibit 100: Tissue Regenix Group Plc - Segment focus
Exhibit 101: Tissue Regenix Group Plc - Key offerings
Exhibit 102: Tissue Regenix Group Plc - Key customers
Exhibit 103: Zimmer Biomet Holdings Inc. - Vendor overview
Exhibit 104: Zimmer Biomet Holdings Inc. - Product segments
Exhibit 105: Zimmer Biomet Holdings Inc. - Organizational developments
Exhibit 106: Zimmer Biomet Holdings Inc. - Geographic focus
Exhibit 107: Zimmer Biomet Holdings Inc. - Segment focus
Exhibit 108: Zimmer Biomet Holdings Inc. - Key offerings
Exhibit 109: Zimmer Biomet Holdings Inc. - Key customers
Exhibit 110: Validation techniques employed for market sizing
Exhibit 111: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Biomatlante SA
- DENTSPLY SIRONA Inc.
- Envista Holdings Corp.
- Geistlich Pharma AG
- Henry Schein Inc.
- Medtronic Plc
- MORE
The following companies as the key players in the global dental biomaterials market: Advanced Medical Solutions Group Plc, Biomatlante SA, DENTSPLY SIRONA Inc., Envista Holdings Corp., Geistlich Pharma AG, Henry Schein Inc., Medtronic Plc, Straumann Holding AG, Tissue Regenix Group Plc, and Zimmer Biomet Holdings Inc.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the technological advances and innovations in dental biomaterials.”
According to the report, one of the major drivers for this market is the increasing prevalence of dental conditions.
Further, the report states that one of the major factors hindering the growth of this market is the complications with dental bone grafts.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the technological advances and innovations in dental biomaterials.”
According to the report, one of the major drivers for this market is the increasing prevalence of dental conditions.
Further, the report states that one of the major factors hindering the growth of this market is the complications with dental bone grafts.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- Advanced Medical Solutions Group Plc
- Biomatlante SA
- DENTSPLY SIRONA Inc.
- Envista Holdings Corp.
- Geistlich Pharma AG
- Henry Schein Inc.
- Medtronic Plc
- Straumann Holding AG
- Tissue Regenix Group Plc
- Zimmer Biomet Holdings Inc.
Note: Product cover images may vary from those shown
LOADING...
